Mylan Receives Approval for Generic Version of Catapres-TTS

Full story:
Mylan announced that its subsidiary Mylan Technologies Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Clonidine Transdermal System USP, 0.1 mg/day, 0.2 mg/day and 0.3 mg/day, the generic version of Boehringer Ingelheim's Catapres-TTS, a treatment for hypertension. Full Story


#1 Dec 5, 2010
I hate the present generic large patch for Catapress. Will the new Mylan generic be any better?

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Mylan Laboratories Discussions

Title Updated Last By Comments
Senator Manchin: What My Daughter Did Should Be... Sep 12 anananana 2
Mylan Launches Generic Version of Famvir Tablets (Apr '11) Jun '14 Chubbs 3
Teva announces favorable court ruling in litiga... (Oct '13) Oct '13 Apotex 1
Mylan Receives Generic Ambien Approval (May '07) Oct '13 Orelee 6
Mylan's Higher Dose Generic Prozac OK'ed (May '07) Sep '13 Randy 2
Mylan Inc. Tries to Get Its Hands on Ranbaxy La... (Dec '12) Dec '12 Jrseyan 1
Generic Version of Ditropan Granted Final Approval (Feb '07) Jul '12 Bear 6

Mylan Laboratories People Search

Addresses and phone numbers for FREE